This inventor holds 2 USPTO granted patents and 3 EPO patents. Top assignee: Idorsia Pharmaceuticals Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Oliver Allemann: Inventor of CCR6 Receptor Modulators.
Introduction
Oliver Allemann is an inventor based in Allschwil, Switzerland. His patent work focuses on compounds that modulate the CCR6 receptor, a target relevant to research into inflammatory and autoimmune diseases and cancer. His portfolio includes 2 patents.
Latest Patents
- CCR6 receptor modulators. This invention concerns compounds of Formula (I), methods for synthesizing them, and their use as CCR6 receptor modulators. The compounds are described for the prevention or treatment of conditions including inflammatory and autoimmune diseases and cancer.
- Azetidin-3-ylmethanol derivatives as CCR6 receptor modulators. This invention concerns Formula (I) compounds and their synthesis and use as CCR6 receptor modulators for treating or preventing various diseases, conditions, or disorders.
Career Highlights
Allemann is associated with Idorsia Pharmaceuticals Ltd. The supplied information also lists Allemann, Oliver, as a company affiliation.
Collaborations
His listed coworkers include Francis Hubler and Eva Caroff.
Conclusion
Oliver Allemann’s patent portfolio centers on CCR6 receptor modulators and related compounds, reflecting a focus on potential therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile